Organisation paid for research Program year 2024 Source: CMS Open Payments

Metro Urology

Neither a doctor nor a teaching hospital

Research payments

$253,332

97 payments

Through program year 2024, Metro Urology is reported as receiving $253,332 in research payments, across 97 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$21,409	12
2023	Research	$26,140	12
2022	Research	$38,180	10
2021	Research	$18,002	7
2020	Research	$64,192	19
2019	Research	$85,410	37

Breakdown

Who paid Research payments · program years 2019–2024

Medtronic USA, Inc. $135,210 49 payments
Medtronic, Inc. $103,731 41 payments
Boston Scientific Corporation $11,271 5 payments
CryoLife, Inc. $3,120 2 payments

Studies the money was for Research payments · program years 2019–2024

Elite $69,955 24 payments
Titan 2 $45,428 19 payments
BASIC Study $42,726 7 payments
SNM Trial Phase 2 Study $39,410 15 payments
Amplitude $33,691 18 payments
Rezum II Pivotal Study $11,271 5 payments
SNM Trial Phase Study $7,731 7 payments
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot Polysaccharide Hemostatic System $3,120 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.